Work for Onconova Therapeutics, Inc.?

Claim Your Profile

Onconova Therapeutics, Inc. Logo Image

Onconova Therapeutics, Inc.

Onconova Therapeutics, Inc. has reached its limit for report views.

Please check back to see if Onconova Therapeutics, Inc. has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

About Onconova Therapeutics, Inc.

11-50 Employees
Based in Newtown, Pennsylvania

Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). Rigosertib, Onconova's lead candidate, is a proprietary Phase 3 small molecule agent, which the Company believes blocks cellular signaling by targeting RAS effector pathways.

Ticker:
ONTX
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol